Modeling the impact of novel systemic treatments on lung cancer screening benefits.

Gogebakan, Kemal Caglar; Lange, Jane; Slatore, Christopher G; Etzioni, Ruth

Gogebakan, Kemal Caglar; Lange, Jane; Slatore, Christopher G; Etzioni, Ruth.

Afiliação

Gogebakan KC; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Lange J; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Slatore CG; Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, Oregon, USA.
Etzioni R; Division of Pulmonary & Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, USA.

Cancer ; 129(2): 226-234, 2023 01 15.

Article em En | MEDLINE | ID: mdl-36320180

Assuntos

Neoplasias Pulmonares; Humanos; Neoplasias Pulmonares/diagnóstico; Neoplasias Pulmonares/terapia; Neoplasias Pulmonares/epidemiologia; Detecção Precoce de Câncer/métodos; Programas de Rastreamento/métodos; Tomografia Computadorizada por Raios X/métodos; Imunoterapia

Palavras-chave

immunotherapy; lung cancer screening; microsimulation model; screening trial; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google